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Abstract
Background—Psychosocial stress is thought to play a key role in the acceleration of 
immunological aging. This study investigated the relationship between lifetime and past-year 
history of post-traumatic stress disorder (PTSD) and the distribution of T cell phenotypes thought 
to be characteristic of immunological aging.
Methods—Data were from 85 individuals who participated in the community-based Detroit 
Neighborhood Health Study. Immune markers assessed included the CD4:CD8 ratio, the ratio of 
late-differentiated effector (CCR7-CD45RA+CD27-CD28-) to naïve (CCR7+CD45RA
+CD27+CD28+) T cells, the percentage of KLRG1-expressing cells, and the percentage of CD57-
expressing cells.
Results—In models adjusted for age, gender, race/ethnicity, education, smoking status, and 
medication use, we found that past-year PTSD was associated with statistically significant 
differences in the CD8+ T cell population, including a higher ratio of late-differentiated effector to 
naïve T cells, a higher percentage of KLRG1+ cells, and a higher percentage of CD57+ cells. The 
percentage of CD57+ cells in the CD4 subset was also significantly higher and the CD4:CD8 ratio 
significantly lower among individuals who had experienced past-year PTSD. Lifetime PTSD was 
also associated with differences in several parameters of immune aging.
Conclusions—PTSD is associated with an aged immune phenotype and should be evaluated as 
a potential catalyzer of accelerated immunological aging in future studies.
Keywords
Aging; Detroit; Immunity; Immunosenescence; Post traumatic stress disorder; T cells
1. Introduction
Several studies have shown that the T cell repertoire differs greatly between older and 
younger individuals. Most notably, older individuals tend to have a greater abundance of 
late-stage differentiated memory T cells and fewer naïve T cells (Bisset et al., 2004; 
Provinciali et al., 2009; Xu et al., 1993). Psychosocial stress is a key modulator of activity of 
the neuroendocrine system, and in particular, the hypothalamic–pituitary–adrenal axis and 
the sympathetic–adrenal–medullary systems, which are known to affect the immune system 
and contribute to immune aging (Effros, 2011; Pace and Heim, 2011). Moreover, stress has 
been demonstrated to play a key role in T cell homeostasis (Nakata, 2012; Scanlan et al., 
1998).
Post-traumatic stress disorder (PTSD) is a specific stress-related physiological and 
psychological response that can occur after a traumatic event that elicits fear, helplessness or 
horror following the threat of injury or death (American Psychiatric Association, 2013). 
Importantly, PTSD has been implicated in a number of autoimmune comorbidities such as 
rheumatoid arthritis, psoriasis and asthma (Boscarino, 2004; Boscarino et al., 2010; Qureshi 
et al., 2009; Shiratori and Samuelson, 2012), suggesting that the immune system is affected 
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by PTSD. Indeed, increases in serum or mitogen-induced levels of inflammatory cytokines 
including IL-1β, IL-6, TNF-α and dysregulation of the complement cascade have been 
observed among PTSD patients (Gill et al., 2008; Gola et al., 2013; Hovhannisyan et al., 
2010; Spivak et al., 1997; Tucker et al., 2010; von Känel et al., 2010, 2007). These 
immunological changes appear to be controlled at the epigenetic level (Rusiecki et al., 2013; 
Smith et al., 2011; Uddin et al., 2010b). Additionally, shortened leukocyte telomere lengths, 
enhanced T cell responses, a decrease in the population of naïve CD8+ T-cells, and an 
increase in central memory and effector CD8+ T cells have been observed among PTSD 
patients (Ladwig et al., 2013; Pace and Heim, 2011; Sommershof et al., 2009). Taken 
together, PTSD may play a key role in the acceleration of immune aging, broadly defined as 
immunosenesence.
To the best of our knowledge, no studies have assessed the association between PTSD and 
the distribution of T cell phenotypes thought to be characteristic of immunological aging 
using data drawn from a community-based sample. In the present study, we address this gap 
in the literature using data from a community-based sample of adults who participated in the 
Detroit Neighborhood Health Study. Specifically, we examined the association between 
PTSD and the distribution of T cell phenotypes as measured by late-stage differentiated 
poorly or non-proliferative effector (E, CCR7-CD45RA+CD27-CD28-) to naïve (N, 
CCR7+CD45RA+CD27+CD28+) T cell ratio (E:N ratio), the percentage of KLRG1-
expressing cells, and the percentage of CD57-expressing cells in both the CD4+ and CD8+ 
T-cell subsets, as well as the CD4:CD8 T-cell ratio. (Pawelec et al., 2009b; Wikby et al., 
2005b) We hypothesized that individuals who had experienced PTSD would have a higher 
E:N ratio, a greater percentage of KLRG1 and CD57 expressing cells, and a lower CD4:CD8 
ratio compared to trauma-exposed individuals who had not experienced PTSD.
2. Materials and methods
2.1. Study population
The data for this study were derived from the 2008–2009 Detroit Neighborhood Health 
Study (DNHS), a community-based longitudinal study of PTSD and other mental health 
outcomes among adults aged 18 or older living in Detroit. Participants were selected through 
a probability sample of households within Detroit city limits and one adult from each 
household was allowed to respond. Consenting participants were administered a 40-min 
telephone survey using the Composite International Diagnostic Interview which included 
mental and physical health assessments, and then asked to provide blood specimens by 
venipuncture or blood spot. Of the 1547 respondents who participated in the first wave of the 
survey (2008–2009), 612 volunteered blood specimens. Of these 612 subjects with blood 
specimens, a balanced sample of 100 respondents was selected based on socioeconomic 
position (SEP), PTSD, and age. For the selection of this sample, SEP was dichotomized 
based on high school completion or less versus some college or more. PTSD was 
dichotomized based upon the PTSD checklist score described below of <30 or ≥30 
(Weathers and Ford, 1996). Approximately equal proportions of individuals 18–49 years of 
age and 50 years of age or older were selected within each unique combination of PTSD and 
SEP. The sample was limited to only participants that had viable immunological cell 
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phenotype data, resulting in a final sample of 85 subjects spanning 19–83 years of age. The 
DNHS was approved by the institutional review boards at the University of Michigan and 
the University of North Carolina at Chapel Hill.
2.2. Ascertainment of PTSD status
PTSD symptoms were assessed during the baseline phone interview. As described in 
previous work (Uddin et al., 2010b), PTSD history was assessed via a 17-item checklist 
(PCL-C) (Weathers and Ford, 1996), a self-report measure of the Diagnostic and Statistical 
Manual of Mental Disorders (DSM-IV) symptoms of PTSD (American Psychiatric 
Association, 1994), and using additional questions about duration, timing, and impairment 
or disability due to the symptoms. Two PTSD exposures were assessed, including lifetime 
PTSD and past year PTSD. If the participant met all six DSM-IV criteria for PTSD 
(American Psychiatric Association, 1994) for either of two traumatic events over their 
lifetime, the participant was considered a lifetime PTSD case. Lifetime PTSD cases who 
reported experiencing PTSD symptoms in the prior year were additionally classified as past 
year PTSD cases. This measure was validated in the DNHS sample by a trained counselor 
during randomly selected in-person reappraisals among 51 DNHS survey participants using 
the Clinician-Administered PTSD Scale for DSM-IV. Results of validation showed that the 
measure had a sensitivity (SE) of 0.24, specificity (SP) of 0.97, positive predictive value 
(PPV) of 0.80, negative predictive value (NPV) 0.72, and an area under the ROC curve 
(AUC) of 0.76.
2.3. Quantification of T-cell phenotypes
T cell subsets from frozen peripheral blood mononuclear cells (PBMC) as described 
previously (Weckle et al., 2015). Briefly, PBMCs were purified from whole blood by 
centrifugation through a Ficoll gradient-containing tube (BD Vacutainer CPT). PBMCs were 
isolated within two hours of blood draw. Cells were frozen at a controlled rate using a 
freezing medium of 10% Dimethyl Sulfoxide (DMSO)/20% Fetal Bovine Serum (FBS)/70% 
(Roswell Park Memorial Institute 1640). Frozen samples were stored at −80 °C and after 24 
h were transferred to a cryobox and put in a liquid nitrogen tank. The samples were shipped 
on dry ice and analyzed within a year of the collection date using 10-color flow cytometry 
methods described previously (Derhovanessian et al., 2013) by the Tübingen Ageing and 
Tumor Immunology Group at the University of Tübingen, Germany. All staining steps were 
performed in PFEA buffer (PBS, 2% FCS, 2 mM EDTA and 0.01% Azide). Cryopreserved 
PBMCs were thawed and treated with human immunoglobulin, GAMUNEX and ethidium 
monoazide (EMA) for 10 min on ice to block Fc receptors on the cells and label non-viable 
cells. Cells were then stained with a primary anti-KLRG-1 antibody (kindly provided by 
Prof. HP Pircher, Freiburg, Germany) for 20 min at 4°C followed by staining with Pacific-
Orange-conjugated goat-anti-mouse secondary antibody for another 20 min on ice. Mouse 
serum was added for 15 min to block non-specific binding to anti-mouse secondary 
antibody, followed by addition of directly-conjugated monoclonal antibodies (mAb), CD3-
AlexaFluor 700, CD4-PerCP, CD8-APC-Cy7, CD27-APC, CD28-PE, CD45RA-Pacific 
Blue, CCR7-PE-Cy7, and CD57-FITC. After 20 min incubation on ice in the dark, cells 
were washed twice and measured immediately on a BD-LSR-II flow cytometer with 
FACSDiva software. The spectral overlap between all channels was calculated automatically 
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by the BD FACSDiva software after measuring negative and single-color controls. DNHS 
samples were compared to PBMCs from the same healthy donor to detect any technical bias 
in measurement.
Flow cytometry data were analyzed using FlowJo software (Tree Star, Portland, OR) and T 
cell subsets were characterized by surface expression as described previously 
(Derhovanessian et al., 2010). T cell data consisted of percentages of T cells (CD3+) out of 
total lymphocytes, and were characterized as CD4+ (CD3+CD4+CD8-) or CD8+ 
(CD3+CD8+CD4-). CD4+ and CD8+ T cells were further analyzed based on surface 
expression of markers to determine the percentage of naïve T cells (N, CCR7+CD45RA
+CD27+CD28+) and the percentage of late-stage differentiated poorly or non-proliferative 
effector cells (E, CCR-CD45RA+CD27-CD28-, also known as TEMRA cells) (Romero et 
al., 2007). In addition, we quantified the percentage of KLRG1+ and CD57+ cells within the 
CD4 and CD8 T cells subsets. These data were used to generate seven out-comes for the 
analysis, including three ratio measures: (1) CD4:CD8 ratio, (2) E:N ratio among CD4+ T 
cells, (3) E:N ratio among CD8+ T cells, and four percentage measures: (4) percentage of 
KLRG1+ cells among CD4+ T cells, (5) percentage of KLRG1+ cells among CD8+ T cells, 
(6) percentage of CD57+ cells among CD4+ T cells, and (7) percentage of CD57+ cells 
among CD8+ T cells. All of the T cell outcomes were treated as continuous variables and 
the three ratio outcomes (CD4:CD8 ratio, CD4 E:N ratio, and CD8 E:N ratio) were natural 
log-transformed to approximate a normal distribution.
2.4. Assessment of covariates
Covariates hypothesized to be potential confounders of the association between PTSD and 
markers of immune aging included age, gender, race/ethnicity, SEP, cigarette use, and 
medication use. These factors have been shown to predict other measures of immune status 
and may also be correlated with PTSD. Age was treated continuously and divided by 10 in 
order to produce estimates based on a 10-year increase in age for ease of interpretation. 
Individuals self-reported their race/ethnicity and this variable was dichotomized as Black/
African American or other. SEP was defined based on educational attainment and 
dichotomized as: high school completion or less versus some college or more. Lifetime 
history of cigarette use was self-reported and individuals were categorized as ever versus 
never smokers. Medications were assessed at the time of the blood draw, during which 
clinicians recorded the name, dosage, and frequency of all prescription and over-the-counter 
medications taken by the participant in the past month. Medication names were entered into 
a database and classified according to the Centers for Disease Control and Prevention 
Ambulatory Care Drug Database System (Centers for Disease Control and Prevention, 
2005). We created groups of drugs for treatment categories that could be correlated with 
immune function (i.e., antimicrobial agents, cardiovascular-renal drugs, central nervous 
system medications, metabolic and nutrient agents, hormones and agents affecting hormonal 
mechanisms, immunologic agents, oncolytics, and drugs used for relief of pain). For 
analytical purposes, medication usage was dichotomized as currently taking any medication 
that may impact immune function or not.
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2.5. Statistical analysis
All statistical analyses were carried out using SAS version 9.3 (SAS Institute, Inc., Cary, 
NC). Descriptive statistics were used to describe the overall sociodemographic and clinical 
characteristics of the study populations. Counts and proportions were estimated to assess the 
distribution of categorical variables and medians with interquartile ranges (IQR) were 
estimated for continuous variables. We also assessed the age-adjusted associations between 
participant characteristics and the three T-cell ratio outcome measures (CD4:CD8 ratio, CD4 
E:N ratio, and CD8 E:N ratio) using ordinary least-squares (OLS) linear regression, as well 
as the age-adjusted associations between participant characteristics and the four T-cell 
percentage outcome measures (CD4%KLRG1+, CD4%CD57+, CD8%KLRG1+, and 
CD8%CD57+) using beta regression in order to accommodate the skewed outcome 
distributions, with the best fit parameterization of the precision model for each participant 
characteristic.
Next, we estimated the associations between past year and lifetime history of PTSD and 
each of the T-cell outcome measures, separately. OLS linear regression was used to estimate 
the association between the two PTSD measures and ratio outcomes and beta regression to 
estimate the association between PTSD measures and percentage outcomes. These models 
were first adjusted for age, gender, race/ethnicity, and education and then additionally 
adjusted for smoking status and medication use. Age was used as the only precision 
parameter for the beta regression models. For all analyses, estimates with a P value <0.05 
were considered statistically significant.
We conducted two secondary analyses. In the first, we additionally adjusted the associations 
between past year and lifetime history of PTSD and each of the T-cell outcome measures for 
cytomegalovirus (CMV) seropositivity, as CMV is thought to be a primary contributor to 
age-related declines in T-cell mediated immunity (Derhovanessian et al., 2011; Hadrup et al., 
2006; Khan et al., 2002; Pawelec, 2014; Pawelec and Derhovanessian, 2011a; Pawelec et al., 
2009a) and PTSD has been linked to increases in CMV IgG antibody levels (Uddin et al., 
2010a). CMV serostatus was assessed in frozen serum samples, which were shipped on dry 
ice to the Stanley Neurovirology Laboratory of the Johns Hopkins University School of 
Medicine in Baltimore, Maryland. The presence and quantity of serum IgG antibodies to 
CMV were tested via solid phase enzyme-linked immunosorbent assays (ELISAs), as 
described previously (Dickerson et al., 2003). Briefly, diluted aliquots of serum were reacted 
with antigen bound to a solid-phase surface. Quantitation of virus-specific IgG was 
determined by reaction of bound antibodies with enzyme labeled anti-human IgG and 
enzyme substrate; optical densities were read by spectrophotometric instrumentation. For 
each sample, the antibody levels were expressed as the ratio of the optical density of a test 
sample to that of a standard sample assayed in each test run. Individuals were categorized as 
seropositive for CMV if their OD ratio value was ≥1.0.
In the next secondary analysis, we examined whether PTSD symptom severity showed 
consistent associations with the T-cell outcomes. In this analysis, a variable for PTSD 
symptom severity was created by summing participant scores (1–5, with 1 indicating no 
symptoms) for each of 17 questions that assessed the severity of psychological symptom 
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associated with the trauma that led to their PTSD, as has been done in previous studies 
(Sipahi et al., 2014). Thus, the scores for each individual could range from 17 to 85.
3. Results
Participants' sociodemographic and clinical characteristics by PTSD status is shown in Table 
1. Overall, participants were a median of 44 years of age (IQR: 35–54 years) and 81.2% 
were Black or African American. Females, who made up 62.4% of the study population, 
were slightly older than males (median age 47 versus 39 years). Slightly less than half 
(48.2%) of participants had more than a high school education. Of the 85 participants, 
22.4% ever experienced PTSD in their lifetime and 16.5% reported experiencing PTSD in 
the past year. Compared to individuals who had never experienced PTSD, individuals who 
had experienced PTSD in the past year were slightly less likely to identify as Black or 
African American and slightly more likely to be female and to have smoked cigarettes.
Table 2 shows the age-adjusted association between participants' sociodemographic and 
clinical characteristics and each T-cell outcome. Increasing age was significantly associated 
with a higher E:N ratio, a higher percentage of KLRG1+ cells, and a higher percentage of 
CD57+ cells in both the CD4 and CD8 T cell subsets. Females had a significantly lower E:N 
ratio in the CD8 T cell subset only. Self-identification as Black or African American was 
also associated with a more aged phenotype for all of the T cell outcomes, but the 
associations were not statistically significant. The distribution of each T cell outcome by 
PTSD status is shown in Fig. 1.
The covariate-adjusted associations between past year PTSD and each T cell outcome are 
shown in Fig. 2. Adjusting for sociodemographics, smoking, and medication use (Model 2), 
we observed that individuals who had experienced PTSD in the past year had a 1.52 (95% 
CI: 0.56, 2.48) log-unit increase in the E:N ratio, a 0.32 (95% CI: 0.12, 0.52) unit increase in 
the percentage of KLRG1-expressing cells, and a 0.44 (95% CI: 0.17, 0.72) unit increase in 
the percentage of CD57-expressing cells in the CD8+T cell subset compared to individuals 
who had not experienced PTSD in the past year. Individuals who had experienced PTSD in 
the past year also showed similar increases in the CD4+ T cell subset, but the difference was 
only statistically significant for the percentage of CD57-expressing cells after adjusting for 
the full set of covariates. The covariate-adjusted associations between lifetime PTSD and 
each T cell outcome are shown in Fig. 3. The associations for lifetime PTSD were similar to 
those for past-year PTSD, but only the associations with the CD8 E:N ratio was statistically 
significant. Moreover, both lifetime (β: −0.32 [95% CI: −0.53, −0.10]) and past-year PTSD 
(β: −0.45 [95% CI: −0.68, −0.21]) were significantly associated with a decrease in CD4:CD8 
ratio.
Supplemental Table 1 shows the covariate-adjusted associations between both past year and 
lifetime PTSD and each T cell outcome, additionally adjusting for cytomegalovirus 
seropositivity (see Models 3). Statistical significance remained unchanged for all 
associations, except that the association between lifetime PTSD and the CD8 E:N ratio was 
no longer statistically significant. Supplemental Table 2 shows the results for the analysis of 
PTSD symptom severity and the T cell outcomes, which were not statistically significant.
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4. Discussion
This is the first study to examine the association between PTSD and immune aging using 
data drawn from a community-based study of individuals spanning a broad age range (19–83 
years of age). We found that past year PTSD was significantly associated with a decrease in 
CD4:CD8 ratio, an increase in CD8 E:N ratio, increases in the populations of KLRG1- and 
CD57-expressing CD8+ T cells cells, and an increase in CD57+ CD4+ T cells even after 
adjusting for age, demographics, smoking, and medication use. Consistent associations were 
observed for lifetime PTSD, with statistically significant associations observed for the 
CD4:CD8 and CD8 E:N ratios. Taken together, our results suggest that exposure to PTSD 
may influence immunological aging.
Our findings are consistent with prior studies conducted in clinical populations that have 
demonstrated that PTSD patients have a lower percentage of naïve CD8+ T cells, a higher 
percentage of memory (CD45RA-) CD8+ T cells, and a lower percentage of regulatory 
(CD4+CD25+FoxP3+) T cells compared to controls (Morath et al., 2014; Sommershof et al., 
2009). While participants in these studies were refugees with a history of war and torture 
experience residing in Germany, ours is the first to study the association between PTSD and 
immune aging in a US community-based sample spanning a broad age range (Morath et al., 
2014; Sommershof et al., 2009). Although we did not assess regulatory T cells as was done 
in in the previous studies, we did assess the ratio of CD4:CD8 T cells, as well as the 
percentage of KLRG1- and CD57-expressing cells in the CD4+ and CD8+ T cell subsets. 
CD4:CD8 ratio inversion is a marker of altered immune function associated with increased 
morbidity and mortality (Ferguson et al., 1995). KLRG1 and CD57 are surface receptors that 
deliver negative signals to the cells bearing them and are commonly considered as markers 
of the latest stage of T cell differentiation and potentially true senescence (Brenchley et al., 
2003; Derhovanessian et al., 2010; Voehringer et al., 2002). Our focus on late-stage 
differentiated T cells (i.e., effector or TEMRA CCR7-CD45RA+CD27-CD28-), based on the 
studies of Romero et al. (2007), allowed us to obtain a more complete picture of the immune 
phenotype of study participants than previous studies. Thus, in addition to supporting 
previously reported findings pertaining to the accumulation of end stage memory T cells and 
depletion of the naïve T cell pool among those with PTSD, we also show decreased 
CD4:CD8 ratio and increases in KLRG1- and CD57-expressing CD8+ cells among those 
with past year PTSD, suggesting an aged immune system phenotype among those with 
recent PTSD.
In the present paper, we focus on the distribution of T cell phenotypes that research suggests 
are key biomarkers of immunosenescence (Lang et al., 2013; Pawelec, 2012). 
Immunosenescence has been an intensive area of research because it has been shown to 
adversely affect not just immune response to novel infection, but also susceptibility to and 
morbidity associated with a range of health conditions (Lang et al., 2013; Pawelec and 
Derhovanessian, 2011b; Wikby et al., 2005a, 2006). Indeed, older individuals have an 
increased incidence of infectious diseases, autoimmune disorders, immunodeficiencies, 
allergies, and cancer compared to younger individuals. Older individuals also respond less 
effectively to interventions that target the immune system, such as immunizations and cancer 
immunotherapy. However, while the T cell outcomes assessed in this observational study 
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provide key information on general immune processes and aging, it should be noted that 
none of these markers provide specific information on the functionality of the immune 
system. Future studies of PTSD in relation to immune system aging that additionally 
incorporate linkages to functionality are warranted. It should also be noted that, in this paper, 
we have focused on the most informative phenotypes of the many different permutations 
possible using polychromatic flow cytometry and presented the most informative results. 
Larger planned studies will be better able to distinguish whether other differentiation stages 
are more or less associated with the outcomes measured.
Another limitation of the present study is that we were unable to ascertain timing in regards 
to exposure to early life stress and PTSD onset. Although we did not have specific 
information on early life stress, we did have information on early life trauma exposure and 
these events were captured in our PTSD exposure assessment. We also did not examine the 
potential influence of comorbid mental health conditions given our limited sample size. As 
almost half (47.4%) of study participants who met the criteria for lifetime PTSD also met 
the criteria for major depressive disorder or generalized anxiety disorder, future studies 
should assess how these potentially interrelated pathways impact the immunological 
outcomes examined here.
In our analysis, we differentiated between associations resulting from past year PTSD and 
lifetime PTSD, revealing that the impact of PTSD on the immune system may be greatest in 
the period directly following episodes of PTSD symptoms. Indeed, Sommershof et al. 
(2009) demonstrated a dose–response-like effect of trauma on T cell outcomes whereby a 
trauma-exposed non-PTSD group displayed a phenotype intermediate to the PTSD and 
control groups. Alternatively, it is possible that alterations to the T-cell repertoire resulting 
from trauma exposure may reverse over time. However, an intervention study testing the 
impact of narrative exposure therapy on PTSD symptoms and T cell outcomes found no 
impact on naïve or memory T cell percentages although PTSD symptoms were alleviated in 
the intervention group (Morath et al., 2014). We found that most T cell changes associated 
with experiencing PTSD in the past year were also associated with ever experiencing PTSD, 
although the associations were not as strong and in some instances not statistically 
significant. An important limitation of the present study is that the small sample size (n = 
85) may have precluded detection of statistically significant results for some associations. 
Nonetheless, these results support the conclusion that recent PTSD symptoms are more 
robustly associated with concurrent signs of an aged immune system than lifetime PTSD. 
While it is possible that lifetime PTSD may play a smaller role in immune system aging, 
further prospective studies are needed to identify whether lifetime PTSD symptoms lead to 
life long immune aged profiles or whether the effects wane over time.
Overall, the present study adds to the mounting evidence from the literature that PTSD is 
associated with a phenotype of accelerated immune system aging (Lohr et al., 2015). The 
exact mechanisms underlying these associations remain unclear, but it is likely that the 
psychosocial stress associated with PTSD has strong influences on the neuroendocrine 
system, which may directly and indirectly contribute to immune aging, for example through 
the hypothalamic–pituitary–adrenal axis and the sympathetic–adrenal–medullary systems 
(Effros, 2011; Pace and Heim, 2011). Moreover, evidence suggests that individuals who 
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experience PTSD demonstrate a distinct network of immune-system related genes (Breen et 
al., 2015) and future studies in this area may help uncover whether lower methylation in 
immune-system related genes or higher expression in those genes may be driving the T cell 
phenoytpoes observed in the present study. More research of mechanisms underlying the 
association between PTSD and immune system aging are warranted and future studies 
assessing the outcome of PTSD-specific therapies should assess whether the detrimental 
effects of PTSD on the immune system can be reversed.
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Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
Distribution of T cell phenotypes by PTSD status among 85 participants in the Detroit 
Neighborhood Health Study.
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Fig. 2. 
Covariate-adjusted associations between Lifetime PTSD and the distribution of T cell 
phenotypes among 85 participants in the Detroit Neighborhood Health Study. Abbreviations: 
PTSD, posttraumatic stress disorder; E:N ratio, ratio of end-stage non-proliferative effector 
cells (E; CCR7-CD45RA+CD27-CD28-orTEMRA) to naïve T-cells (N; CCR7+CD45RA
+CD27+CD28 +).
*P value <0.05.
aModel 1: Association between PTSD and T-cell outcome adjusted for age, gender, race/
ethnicity, and education.
bModel 2: Association between PTSD and T-cell outcome additionally adjusted for smoking 
status and medication use. 3 individuals missing data on medication use were excluded from 
the model.
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Fig. 3. 
Covariate-adjusted associations between Past-Year PTSD and the distribution of T cell 
phenotypes among 85 participants in the Detroit Neighborhood Health Study. Abbreviations: 
PTSD, posttraumatic stress disorder; E:N ratio, ratio of end-stage non-proliferative effector 
cells (E; CCR7-CD45RA+CD27-CD28-orTEMRA) to naïve T-cells (N; CCR7+CD45RA
+CD27+CD28 +).
*P value <0.05.
aModel 1: Association between PTSD and T-cell outcome adjusted for agegender, race/
ethnicity, and education.
bModel 2: Association between PTSD and T-cell outcome additionally adjusted for smoking 
status and medication use. 3 individuals missing data on medication use were excluded from 
the model.
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Table 1
Sociodemographic and clinical characteristics of 85 participants in the Detroit Neighborhood Health Study.
Overall
(N=85)
PTSD status
No PTSD
(N = 66)
Lifetime PTSD
(N=19)
Past year PTSD
(N= 14)
Age in years, median (IQR) 44 (35–54) 44 (35–54) 44 (33–58) 47 (33–58)
Gender, N (%)
 Female 53 (62.4) 41 (62.1) 12 (63.2) 10 (71.4)
 Male 32 (37.7) 25 (37.9) 7 (36.8) 4 (28.6)
Race/ethnicity, N (%)
 Black 69 (81.2) 55 (83.3) 14 (73.7) 10 (71.4)
 Non-black 16 (18.8) 11 (16.7) 5 (26.3) 4 (28.6)
Education, N (%)
 ≤High school 44 (51.8) 33 (50.0) 11 (57.9) 7 (50.0)
 >High school 41 (48.2) 33 (50.0) 8 (42.1) 7 (50.0)
Medication usea, N (%)
 Yes 35 (42.7) 28 (43.7) 7 (38.9) 5 (38.5)
 No 47 (57.3) 36 (56.3) 11 (61.1) 8 (61.5)
Cigarette use in lifetime, N (%)
 Yes 51 (60.0) 37 (56.1) 14 (73.7) 9 (64.3)
 No 34 (40.0) 29 (43.9) 5 (26.3) 5 (35.7)
 PBMC count (Millions of cells), median (IQR) 21.00 (17.60–26.80) 21.52 (17.32–26.25) 20.75 (17.85–29.35) 20.90 (18.10–29.35)
Abbreviations: PTSD, posttraumatic stress disorder; E:N ratio, ratio of end-stage non-proliferative effector cells (E; CCR7-CD45RA+CD27-CD28-
orTEMRA) to naïve T-cells (N; CCR7+CD45RA+CD27+CD28+).
a
Medications included antimicrobial agents, cardiovascular-renal drugs, central nervous system medications, metabolic and nutrient agents, 
hormones and agents affecting hormonal mechanisms, immunologic agents, oncolytics, and drugs used for relief of pain. 3 individuals were 
missing data on medication use.
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